CAR therapies
A2 Biotherapeutics Raises $80M in Series C Funding
The firm will use the funding to advance ongoing clinical trials of its autologous cell therapies for solid tumors.
Galapagos Splitting Into Two Companies, Cutting 300 Jobs, Altering Gilead Licensing Deal
The changes will result in one company focused exclusively on cancer cell therapies and another on strategic transactions to build a pipeline of innovative medicines.
Verismo Therapeutics Receives $4M Investment From Institute for Follicular Lymphoma Innovation
The investment will be used to help increase enrollment of follicular lymphoma patients in an ongoing Phase I study of Verismo's KIR-CAR therapy.
BrainChild Bio Pursuing Pivotal Trial of CAR T Therapy in Pediatric Brain Cancer
The firm has discussed positive Phase I results on BCB-276 with the FDA and plans to move it directly to a registrational trial by year-end.
Carsgen to Seek Approval in China for Satri-Cel in Claudin18.2-Expressing Gastric Cancer
The firm said the Phase III trial met its primary endpoint of improvement in progression-free survival.